Abu Dhabi - People aged between 18 and 60 are eligible to take part as long as they haven't had Covid-19 and have a medical check-up.
- ???? ?????? ???????? (@admediaoffice) July 16, 2020
The trials are the result of a partnership between Abu Dhabi based G42 Healthcare, currently at the forefront of the battle against Covid-19 in the UAE, and Sinopharm CNBG, the world's sixth largest vaccine manufacturer.
- ???? ?????? ???????? (@admediaoffice) July 16, 2020
The trials are being operated by health practitioners from Abu Dhabi Health Services Company (Seha), who are operating facilities at five of their sites in Abu Dhabi and Al Ain in addition to a mobile clinic to ensure the trials are readily accessible to volunteers participating in the programme.
The UAE was the preferred choice to conduct the Phase III trials for the inactive Covid-19 vaccine because of its demographic heterogeneity, allowing for robust research across multiple ethnicities and increasing its feasibility for global application to the success of the trials.